Robert Motzer

2 Podcast Episodes

TIVO 1 study shows tivozanib an option for renal cell carcinoma: Dr Robert Motzer - Memorial Sloan Kettering Cancer Centre

TIVO 1 study shows tivozanib an option for renal cell carcinoma: Dr Robert Motzer - Memorial Sloan Kettering Cancer Centre

Dr Motzer talks to ecancer at the 2013 ASCO GU symposium. TIVO 1 study shows tivozanib an option for renal cell carcinom... Read more

7 Mar 2013

6mins

RCCU1 2008 | Interview with Robert Motzer, MD

RCCU1 2008 | Interview with Robert Motzer, MD

RenalCellCancerUpdate.com – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Car... Read more

16 Apr 2008

34mins

Similar People

“Podium: AI tools for podcasters. Generate show notes, transcripts, highlight clips, and more with AI. Try it today at https://podium.page”